Everest Organics Ltd is Rated Sell

Current Rating and Its Significance

MarketsMOJO’s 'Sell' rating for Everest Organics Ltd indicates a cautious stance towards the stock, suggesting that investors may want to consider reducing exposure or avoiding new purchases at this time. This rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment potential in the Pharmaceuticals & Biotechnology sector.

Quality Assessment: Below Average Fundamentals

As of 11 March 2026, Everest Organics exhibits below average quality metrics. The company’s long-term fundamental strength is weak, with a compounded annual growth rate (CAGR) of operating profits declining by 12.16% over the past five years. This negative growth trend signals challenges in sustaining profitability and operational efficiency. Additionally, Everest Organics has a high Debt to EBITDA ratio of 6.46 times, indicating a significant debt burden relative to its earnings before interest, taxes, depreciation, and amortisation. This elevated leverage raises concerns about the company’s ability to service its debt obligations comfortably.

Return on Equity (ROE), a key measure of profitability relative to shareholders’ funds, averages at a modest 5.58%. This low ROE suggests that the company is generating limited returns for its investors, which is a critical consideration for those seeking value creation through equity investments.

Valuation: Fair but Not Compelling

The valuation grade for Everest Organics is assessed as fair. While the stock does not appear excessively overvalued, it also lacks the attractive pricing that might entice value-focused investors. Given the company’s weak fundamental quality and financial challenges, the fair valuation does not provide a sufficient margin of safety or upside potential to offset the risks inherent in the business.

Financial Trend: Positive but Insufficient

Despite the weak quality indicators, the financial trend grade is positive. This suggests that some recent financial metrics or operational improvements have been noted, potentially reflecting short-term gains or stabilisation efforts. However, these positive trends have not yet translated into a stronger overall financial position or improved profitability metrics that would warrant a more favourable rating.

Technical Outlook: Mildly Bearish

From a technical perspective, Everest Organics is currently mildly bearish. The stock’s price movements and chart patterns indicate downward momentum or limited buying interest in the near term. This technical sentiment aligns with the broader fundamental concerns and supports the cautious 'Sell' rating.

Stock Performance Snapshot

As of 11 March 2026, Everest Organics has experienced mixed returns over various time frames. The stock gained 1.27% on the most recent trading day and has risen 11.13% over the past week. However, it has faced significant declines over longer periods, including a 27.72% drop in the last month, a 35.99% fall over three months, and a 25.63% decrease in six months. Year-to-date, the stock is down 39.28%, although it has delivered a positive 27.27% return over the past year. These volatile returns reflect the uncertainty surrounding the company’s prospects and market sentiment.

Market Capitalisation and Sector Context

Everest Organics is classified as a microcap company within the Pharmaceuticals & Biotechnology sector. Microcap stocks often carry higher risk due to lower liquidity and greater sensitivity to operational challenges. Investors should weigh these risks carefully, especially given the company’s current financial and technical profile.

What This Rating Means for Investors

For investors, the 'Sell' rating on Everest Organics Ltd serves as a cautionary signal. It suggests that the stock currently carries elevated risks relative to its potential rewards. The combination of weak long-term fundamentals, high leverage, modest profitability, and a mildly bearish technical outlook implies that the stock may underperform or face continued volatility in the near term.

Investors should consider their risk tolerance and portfolio objectives carefully before maintaining or initiating positions in Everest Organics. Those seeking stable growth or income may find more attractive opportunities elsewhere, particularly in companies with stronger financial health and clearer growth trajectories.

Summary of Key Metrics as of 11 March 2026

To recap, the latest data shows:

• Mojo Score: 31.0, reflecting a 'Sell' grade
• Operating profit CAGR over 5 years: -12.16%
• Debt to EBITDA ratio: 6.46 times, indicating high leverage
• Average Return on Equity: 5.58%
• Stock returns: +1.27% (1 day), -27.72% (1 month), +27.27% (1 year)
• Technical grade: mildly bearish

These figures collectively underpin the current cautious stance on the stock.

Looking Ahead

While Everest Organics shows some positive financial trends, the overall outlook remains subdued. Investors should monitor upcoming quarterly results, debt management initiatives, and any strategic developments that could improve the company’s quality and valuation metrics. Until then, the 'Sell' rating reflects a prudent approach based on the present data.

Conclusion

Everest Organics Ltd’s current 'Sell' rating by MarketsMOJO, last updated on 16 February 2026, is grounded in a thorough analysis of the company’s quality, valuation, financial trend, and technical factors as of 11 March 2026. The rating advises investors to exercise caution given the company’s weak fundamentals, high leverage, and bearish technical signals. Staying informed on the company’s evolving financial health will be essential for making well-informed investment decisions going forward.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →